Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Covington
Federal Trade Commission
Healthtrust
Merck
Deloitte
AstraZeneca
Chubb
Teva

Generated: April 25, 2018

DrugPatentWatch Database Preview

Valrubicin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for valrubicin and what is the scope of valrubicin patent protection?

Valrubicin
is the generic ingredient in one branded drug marketed by Endo Pharm and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for valrubicin. One supplier is listed for this compound.
Synonyms for valrubicin
(2S-cis)-Pentanoic acid, 2-(1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-.alpha.-L-lyxo-hexopyranosyl)oxy)-2-naphthacenyl)-2-oxoethyl ester
(8S, 10S)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)-alpha-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione 8(2)-valerate
[2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]oxan-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] pentanoate
[2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]tetrahydropyran-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] pentanoate
124V620
136816-53-0
2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-trideoxy-3-[(trifluoroacetyl)amino]hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate
2C6NUM6878
56124-62-0
AC1L9RHG
AD-32
AD32
Adriamycin, trifluoroacetyl-, 14-valerate
AKOS027327568
AOB2165
C34H36F3NO13
CAS-56124-62-0
CHEBI:135876
CHEMBL1096885
CS-2929
D02697
DB00385
DSSTox_CID_26497
DSSTox_GSID_46497
DSSTox_RID_81666
DTXSID9046497
EX-A493
FT-0655298
HSDB 7288
HY-13772
KB-276091
MolPort-020-005-895
N-Trifluoroacetyladriamycin 14-valerate
N-Trifluoroacetyladriamycin-14-valerate
N-Trifluoroacetyldoxorubicin 14-valerate
NCGC00164738-01
NSC 246131
NSC-246131
NSC246131
Q-101408
SCHEMBL12824
Tox21_112257
UNII-2C6NUM6878
Valrubicin (AD-32)
Valrubicin (USP/INN)
Valrubicin [USAN:USP:INN]
Valrubicina
Valrubicine
Valrubicinum
Valstar
Valstar (TN)
Valtaxin
Z-3187
ZINC49783788

US Patents and Regulatory Information for valrubicin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Pharm VALSTAR PRESERVATIVE FREE valrubicin SOLUTION;INTRAVESICAL 020892-001 Sep 25, 1998 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Covington
Federal Trade Commission
QuintilesIMS
Citi
Julphar
Accenture
Daiichi Sankyo
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.